Dr. Reddy's Laboratories Limited (RDY)

Dr. Reddy's Laboratories Stock Forecast

Stock Price Forecast

According to 5 analysts polled by S&P Global, Dr. Reddy's Laboratories stock has a consensus rating of "Hold" and an average price target of $14.03. The average 1-year stock price forecast is 3.16% higher than the current stock price, while the lowest is $11.3 (-16.91%) and the highest is $16.55 (+21.69%).

Price Target: $14.03 (+3.16%)

Analyst Consensus: Hold

Target	Low	Average	Median	High
Price	$11.3	$14.03	$13.88	$16.55
Change	-16.91%	+3.16%	+2.06%	+21.69%

* Price targets were last updated on Jun 5, 2025.

Analyst Ratings

The average analyst rating for Dr. Reddy's Laboratories stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Rating	Jan '25	Feb '25	Mar '25	Apr '25	May '25	Jun '25
Strong Buy	0	0	0	0	0	1
Buy	1	1	1	1	1	0
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	1	1	1	1	1	1

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Damayanti Kerai HSBC	HSBC	Hold → Strong Buy Upgrades $14 → $17	Hold → Strong Buy	Upgrades	$14 → $17	+24.26%	Jun 5, 2025
Balaji Prasad Barclays	Barclays	Buy Maintains $17 → $17	Buy	Maintains	$17 → $17	+25.00%	Nov 6, 2024
Balaji Prasad Barclays	Barclays	Buy Maintains $16 → $17	Buy	Maintains	$16 → $17	+27.94%	Jul 30, 2024
Balaji Prasad Barclays	Barclays	Buy Maintains $16 → $16	Buy	Maintains	$16 → $16	+19.12%	May 8, 2024
Balaji Prasad Barclays	Barclays	Buy Maintains $15 → $16	Buy	Maintains	$15 → $16	+17.65%	Jan 29, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

362.58B

Increased by 7.93%

from 335.93B

Revenue Next Year

396.01B

Increased by 9.22%

from 362.58B

EPS This Year

55.90

Increased by 8.70%

from 51.42

EPS Next Year

64.98

Increased by 16.25%

from 55.90

Fiscal Year	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027	FY 2028
Period Ending	Mar 31, 2022	Mar 31, 2023	Mar 31, 2024	Mar 31, 2025	Mar 31, 2026	Mar 31, 2027	Mar 31, 2028
Revenue	214.39B	245.88B	279.16B	325.54B	335.93B	362.58B	396.01B
Revenue Growth	13.00%	14.69%	13.54%	16.61%	3.19%	7.93%	9.22%
EPS	28.34	54.17	66.80	67.78	51.42	55.90	64.98
EPS Growth	36.70%	91.16%	23.32%	1.47%	-24.14%	8.70%	16.25%
Forward PE	-	-	-	-	-	23.29	20.03
No. Analysts	-	-	-	-	-	41	40

Financial currency is INR. Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2027	2028	2029	2030
High	413.6B	448.4B
Avg	362.6B	396.0B
Low	327.4B	356.2B

Revenue Growth

Revenue Growth	2027	2028	2029	2030
High	23.1%	23.7%
Avg	7.9%	9.2%
Low	-2.5%	-1.7%

EPS Forecast

EPS	2027	2028
High	69.41	80.85
Avg	55.90	64.98
Low	42.16	48.47

EPS Growth

EPS Growth	2027	2028
High	35.0%	44.6%
Avg	8.7%	16.2%
Low	-18.0%	-13.3%

Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.